|
Market Closed -
Other stock markets
|
Pre-market 06:32:57 | |||
| 26.30 EUR | +2.18% |
|
26.40 | +0.38% |
| 06:41am | ?Societe Generale SA Holds 5.07% Of Total Voting Rights And Instruments In Gerresheimer AG As Of Dec 1 | RE |
| 12-11 | Schott Pharma Banks on 'Intact Trends'--Eyes Expansion in US and China | DP |
| Capitalization | 908M 1.07B 848M 796M 1.47B 96.31B 1.6B 9.88B 3.84B 45.49B 4.01B 3.92B 166B | P/E ratio 2025 * |
48.7x | P/E ratio 2026 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise value | 2.95B 3.47B 2.76B 2.59B 4.78B 313B 5.21B 32.11B 12.48B 148B 13.02B 12.75B 539B | EV / Sales 2025 * |
1.27x | EV / Sales 2026 * | 1.18x |
| Free-Float |
96.72% | Yield 2025 * |
2% | Yield 2026 * | 2.76% |
Last Transcript: Gerresheimer AG
| 1 day | +0.38% | ||
| 1 week | +0.23% | ||
| Current month | -0.90% | ||
| 1 month | +8.32% | ||
| 3 months | -37.62% | ||
| 6 months | -45.07% | ||
| Current year | -62.96% |
| 1 week | 22.6 | 26.3 | |
| 1 month | 22.6 | 27.36 | |
| Current year | 22.6 | 85.25 | |
| 1 year | 22.6 | 85.25 | |
| 3 years | 22.6 | 122.9 | |
| 5 years | 22.6 | 122.9 | |
| 10 years | 22.6 | 122.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 21/06/2010 | |
Wolf Uwe Lehmann
DFI | Director of Finance/CFO | 54 | 31/08/2025 |
Guido Pickert
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Francesco Grioli
BRD | Director/Board Member | 53 | 31/12/2010 |
Axel Herberg
CHM | Chairman | 67 | 29/04/2015 |
Markus Rocholz
BRD | Director/Board Member | 55 | 25/04/2012 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.18% | +0.23% | -65.58% | -58.52% | 1.07B | ||
| +0.60% | -1.69% | +8.01% | +14.67% | 214B | ||
| -1.01% | -2.20% | +20.30% | +26.92% | 128B | ||
| +1.09% | +2.03% | +48.56% | +108.37% | 66.83B | ||
| +1.02% | +3.44% | -9.32% | -19.05% | 57.21B | ||
| +1.79% | -0.02% | +16.59% | +73.21% | 51.16B | ||
| +2.04% | +5.66% | -14.33% | -40.80% | 26.89B | ||
| -2.45% | -3.27% | +20.45% | +31.53% | 24.78B | ||
| -1.00% | -3.08% | +7.60% | -33.89% | 23.72B | ||
| +0.63% | -2.38% | -25.57% | +15.71% | 21.83B | ||
| Average | +0.31% | -0.57% | +0.67% | +11.82% | 61.57B | |
| Weighted average by Cap. | +0.34% | -0.82% | +12.26% | +25.41% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.32B 2.72B 2.16B 2.03B 3.75B 246B 4.08B 25.2B 9.79B 116B 10.22B 10B 423B | 2.42B 2.84B 2.26B 2.12B 3.91B 256B 4.26B 26.29B 10.22B 121B 10.66B 10.43B 441B |
| Net income | 18.65M 21.92M 17.42M 16.34M 30.21M 1.98B 32.89M 203M 78.84M 934M 82.27M 80.53M 3.4B | 61.64M 72.44M 57.54M 53.99M 99.83M 6.53B 109M 670M 261M 3.09B 272M 266M 11.25B |
| Net Debt | 2.04B 2.4B 1.91B 1.79B 3.31B 217B 3.6B 22.23B 8.64B 102B 9.01B 8.82B 373B | 1.95B 2.3B 1.82B 1.71B 3.17B 207B 3.45B 21.26B 8.26B 97.89B 8.62B 8.44B 357B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/12/25 | 26.30 € | +3.14% | 208,960 |
| 10/12/25 | 25.50 € | +1.03% | 270,526 |
| 09/12/25 | 25.24 € | +1.77% | 601,727 |
| 08/12/25 | 24.80 € | -4.10% | 190,374 |
| 05/12/25 | 25.86 € | -1.45% | 198,141 |
Delayed Quote Xetra, December 11, 2025 at 08:38 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GXI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















